Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
14.52
-0.02 (-0.14%)
Apr 13, 2026, 2:07 PM EDT - Market open
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $878.84 million as of April 13, 2026. Its market cap has increased by 85.66% in one year.
Market Cap
878.84M
Enterprise Value
506.35M
1-Year Change
85.66%
Ranking
Category
Stock Price
$14.52
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $878.84M, an increase of 5.95%. That is a compound annual growth rate of 1.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 880.05M | 43.93% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 933.06M |
| Compass Therapeutics | 931.05M |
| Evommune | 918.83M |
| Xencor | 910.87M |
| Janux Therapeutics | 908.22M |
| Jade Biosciences | 882.27M |
| Fortrea Holdings | 858.33M |
| SELLAS Life Sciences Group | 854.81M |